SOX2 and cytomegalovirus infection: Indeed, quantitative PCR analysis indicated that delivery of CMV70-3P microRNA oligo inhibitor to GSC decreased the expression of SOX2 following by CMV infection (Figure 3C) and led to ∼20% reduction of human SOX2 promoter activity (Supplementary Figure S3) in the presence of CMV70-3P microRNA expression.